Vaxcyte Management
Management criteria checks 3/4
Vaxcyte's CEO is Grant Pickering, appointed in Nov 2013, has a tenure of 10.5 years. total yearly compensation is $12.14M, comprised of 5.3% salary and 94.7% bonuses, including company stock and options. directly owns 0.61% of the company’s shares, worth $43.99M. The average tenure of the management team and the board of directors is 4 years and 5 years respectively.
Key information
Grant Pickering
Chief executive officer
US$12.1m
Total compensation
| CEO salary percentage | 5.3% |
| CEO tenure | 10.5yrs |
| CEO ownership | 0.6% |
| Management average tenure | 4yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans
Dec 27
We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely
Sep 12Here's Why We're Not Too Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Situation
May 30We Think Vaxcyte (NASDAQ:PCVX) Can Afford To Drive Business Growth
Dec 22Vaxcyte appoints new CBO, CMO
Oct 11Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans
Aug 05Vaxcyte completes enrollment in phase 2 portion of study of pneumonia vaccine candidate
Jul 12Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans
Feb 25We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely
Nov 08We're Interested To See How Vaxcyte (NASDAQ:PCVX) Uses Its Cash Hoard To Grow
Jul 26We're Interested To See How Vaxcyte (NASDAQ:PCVX) Uses Its Cash Hoard To Grow
Apr 12CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$12m | US$640k | -US$402m |
| Sep 30 2023 | n/a | n/a | -US$300m |
| Jun 30 2023 | n/a | n/a | -US$265m |
| Mar 31 2023 | n/a | n/a | -US$245m |
| Dec 31 2022 | US$14m | US$601k | -US$223m |
| Sep 30 2022 | n/a | n/a | -US$174m |
| Jun 30 2022 | n/a | n/a | -US$143m |
| Mar 31 2022 | n/a | n/a | -US$118m |
| Dec 31 2021 | US$5m | US$575k | -US$100m |
| Sep 30 2021 | n/a | n/a | -US$92m |
| Jun 30 2021 | n/a | n/a | -US$87m |
| Mar 31 2021 | n/a | n/a | -US$83m |
| Dec 31 2020 | US$3m | US$481k | -US$89m |
| Sep 30 2020 | n/a | n/a | -US$83m |
| Jun 30 2020 | n/a | n/a | -US$73m |
| Mar 31 2020 | n/a | n/a | -US$64m |
| Dec 31 2019 | US$596k | US$426k | -US$50m |
Compensation vs Market: Grant's total compensation ($USD12.14M) is above average for companies of similar size in the US market ($USD8.44M).
Compensation vs Earnings: Grant's compensation has been consistent with company performance over the past year.
CEO
Grant Pickering (55 yo)
10.5yrs
Tenure
US$12,135,683
Compensation
Mr. Grant E. Pickering, M.B.A., is Co-Founder of Vaxcyte, Inc. since 2013 and has been its Chief Executive Officer and Director since November 2013 and served as its President since November 2013 until Dec...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 10.5yrs | US$12.14m | 0.61% $ 44.0m | |
| President & CFO | 4yrs | US$5.42m | 0.044% $ 3.1m | |
| Executive VP & COO | 4.4yrs | US$5.40m | 0.16% $ 11.8m | |
| Senior VP | 2.1yrs | US$3.49m | 0.0063% $ 449.8k | |
| Co-Founder | 11.3yrs | no data | no data | |
| Co-Founder & VP of Research | no data | no data | 0.32% $ 23.1m | |
| Senior VP of Finance & Principal Accounting Officer | 1.3yrs | no data | 0.0021% $ 147.1k | |
| Senior Vice President of Corporate Communications & Investor Relations | no data | no data | no data | |
| Chief People Officer | less than a year | no data | no data | |
| Senior Vice President of Process Development & Manufacturing | 8.1yrs | US$2.35m | 0% $ 0 | |
| Senior Vice President of Commercial Manufacturing & Supply Chain | 2.5yrs | US$1.84m | no data | |
| Senior Vice President of Project Management | no data | no data | no data |
4.0yrs
Average Tenure
54yo
Average Age
Experienced Management: PCVX's management team is considered experienced (4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 10.5yrs | US$12.14m | 0.61% $ 44.0m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.7yrs | US$704.22k | 0.0029% $ 205.9k | |
| Independent Director | 6yrs | US$691.72k | 0.0029% $ 205.9k | |
| Independent Director | 4.1yrs | US$704.22k | 0.0029% $ 205.9k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Chairman of the Board | 2.6yrs | US$724.22k | 0.0029% $ 205.9k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 7.7yrs | US$399.21k | 0.0094% $ 675.1k | |
| Member of Scientific Advisory Board | 7.3yrs | no data | no data | |
| Independent Director | 2.7yrs | US$704.22k | 0.0029% $ 205.9k | |
| Member of Scientific Advisory Board | no data | no data | no data |
5.0yrs
Average Tenure
56yo
Average Age
Experienced Board: PCVX's board of directors are considered experienced (5 years average tenure).